SCHEMBL10047647

SCHEMBL10047647

CC(C)OC1OC(CO)C(OC2OC(CO)C(OC(C)C)C(O)C2O)C(O)C1O

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ TYR P14679 6/20 0.48
▸ AMY1A P0DUB6 2/20 0.46
▸ LGALS8 O00214 1/20 0.46
▸ LGALS3 P17931 1/20 0.46
▸ LGALS4 P56470 1/20 0.46
▸ AMY2A P04746 2/20 0.43
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ GAA P10253 4/20 0.39
▸ MGAM O43451 2/20 0.39
▸ SI P14410 1/20 0.39
▸ CNR1 P21554 1/20 0.39
▸ PTGS1 P23219 1/20 0.39
▸ PDE4A P27815 1/20 0.39
▸ PDE3A Q14432 1/20 0.39
▸ MGAM2 Q2M2H8 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ GLA P06280 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17341181 1.00 TYR (0.48) TYRAMY1ALGALS8LGALS3LGALS4
SCHEMBL13713719 0.94 TYR (0.41) TYRAMY1ALGALS8LGALS3LGALS4
SCHEMBL22224178 0.94 TYR (0.41) TYRAMY1ALGALS8LGALS3LGALS4
SCHEMBL13126159 0.94 TYR (0.41) TYRAMY1ALGALS8LGALS3LGALS4
SCHEMBL12563490 0.92 TYR (0.56) TYRAMY1ALGALS8LGALS3LGALS4
SCHEMBL12901988 0.92 TYR (0.56) TYRAMY1ALGALS8LGALS3LGALS4
SCHEMBL12563491 0.92 TYR (0.56) TYRAMY1ALGALS8LGALS3LGALS4
SCHEMBL12902015 0.92 TYR (0.56) TYRAMY1ALGALS8LGALS3LGALS4
SCHEMBL12604931 0.92 TYR (0.56) TYRAMY1ALGALS8LGALS3LGALS4
SCHEMBL10073936 0.91 AMY2A (0.53) TYRAMY1ALGALS8LGALS3LGALS4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160348053-A1 DISPERSING FEEDSTOCKS AND PROCESSING MATERIALS XYLECO, INC. 2016-12-01 — — US disclosed
US-8568760-B2 Hydrophobic polysaccharides with pendent groups having terminal reactive functionalities and medical uses thereof SURMODICS, INC. (US) 2013-10-29 — — US disclosed
US-20120052107-A9 HYDROPHOBIC POLYSACCHARIDES WITH PENDENT GROUPS HAVING TERMINAL REACTIVE FUNCTIONALITIES AND MEDICAL USES THEREOF SURMODICS MD, LLC 2012-03-01 — — US disclosed
US-20120052107-A9 HYDROPHOBIC POLYSACCHARIDES WITH PENDENT GROUPS HAVING TERMINAL REACTIVE FUNCTIONALITIES AND MEDICAL USES THEREOF SURMODICS MD, LLC 2012-03-01 — — US disclosed
US-20110159067-A1 HYDROPHOBIC POLYSACCHARIDES WITH PENDENT GROUPS HAVING TERMINAL REACTIVE FUNCTIONALITIES AND MEDICAL USES THEREOF SURMODICS, INC. 2011-06-30 — — US disclosed
US-20110159067-A1 HYDROPHOBIC POLYSACCHARIDES WITH PENDENT GROUPS HAVING TERMINAL REACTIVE FUNCTIONALITIES AND MEDICAL USES THEREOF SURMODICS, INC. 2011-06-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120052107-A9 HYDROPHOBIC POLYSACCHARIDES WITH PENDENT GROUPS HAVING TERMINAL REACTIVE FUNCTIONALITIES AND MEDICAL USES THEREOF CD44, FUT6, FUT5 TYR 506/4885AMY1A 720/4885LGALS8 162/4885
US-20110159067-A1 HYDROPHOBIC POLYSACCHARIDES WITH PENDENT GROUPS HAVING TERMINAL REACTIVE FUNCTIONALITIES AND MEDICAL USES THEREOF CD44, FUT6, FUT5 TYR 506/4885AMY1A 720/4885LGALS8 162/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback